- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (630)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (902)
- Research (394)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (606)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Colorectal Cancer Screening Saves Lives
BY Judy Overton
3 minute read | Published March 23, 2012
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 23, 2012
Marta Davila, M.D., continues to see the benefits of colorectal cancer screening.
A physician in MD Anderson's Endoscopy Center, Davila recently treated a presumably healthy 52-year-old man who responded to his wife's encouragement to get a colonoscopy.
"The patient kept postponing his colonoscopy appointment because he felt well. He was diagnosed with early stage colon cancer, underwent surgery and is now cured," says Davila, professor in the Department of Gastroenterology, Hepatology and Nutrition. "He was one of the lucky ones."
According to Davila, preventive colorectal cancer screening is particularly important, especially since patients rarely experience symptoms until the cancer is at an advanced stage.
"The reality is we need to encourage our patients to get a screening test. It's the right thing to do," she says.
Research shows screening saves lives
A recent article published in the New England Journal of Medicine underscored the effectiveness of colonoscopy and colon polyp removal in saving lives. Researchers learned the death rate from colorectal cancer was cut by 53% in patients whose doctors had removed precancerous polyps.
The research included an analysis of more than 2,000 patients between 1980 and 1990, who were referred for initial colonoscopy at National Polyp Study clinical centers. Davila calls the study historical.
"We knew from previous studies that removal of precancerous polyps resulted in a reduction in the incidence of colorectal cancer, but this is the first time a reduction in mortality has been clearly demonstrated."
Screening prep scares away many
Unfortunately, many people avoid the screening because of the preparation necessary to cleanse the colon. Davila says the fear of getting cancer should outweigh any fears people have to prepare for the procedure.
Davila adds, "The preparation is very important because it helps the physician get a clearer view of the colon. Without good visualization, it is impossible to detect precancerous polyps or other lesions."
Are you at risk?
Guidelines are in place for those considered at average, increased or high risk for colorectal cancer.
Patients at average risk for colorectal cancer should undergo screening starting at age 50. Average risk patients are those with:
- no history of adenomas or precancerous polyps,
- no history of inflammatory bowel disease and
- no family history of colon cancer.
Patients with a history of adenomas or precancerous polyps are at increased risk. They should undergo surveillance examinations based on the number and characteristics of the polyps removed. Commonly, these patients undergo colonoscopy about every 3-5 years.
Patients at increased risk due to a positive family history should begin screening at age 40 or 10 years before the youngest case in the immediate family. A positive family history includes:
- colorectal cancer or precancerous polyps in a first-degree relative before age 60 or in two or more first-degree relatives of any age, and
- either colorectal cancer or precancerous polyps in a first-degree relative age 60 or older or in two second-degree relatives with colorectal cancer.
There are patients at very high risk for colorectal cancer because of the presence of other diseases or genetic conditions. They should be seen by experts in those particular diseases, including:
- genetic diagnosis of familial adenomatous polyposis (FAP) or suspected FAP without genetic testing evidence,
- genetic or clinical diagnosis of hereditary nonpolyposis colorectal cancer or individuals at increased risk of it, and
- a history of inflammatory bowel disease (ulcerative colitis or Crohn's disease).
African-Americans may be at higher risk of colorectal cancer and some guidelines would suggest screening starting at age 45.
In the United States, colorectal cancer is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. Colorectal cancer can be prevented by the detection and removal of precancerous polyps. "We urge you to get your screening test," Davila says.
Related Cancerwise Stories
The preparation is very important because it helps the physician get a clearer view of the colon. Without good visualization, it is impossible to detect precancerous polyps or other lesions.
Marta Davila, M.D.
Physician